6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Jun 26, 2024.
The trade is 87.3% of the 14,930 shares held after it.
1 other insider sold within 30 days.
Insider activity: Insider Pudenz Shane sold about $577.9K of CSV on Aug 27, 2025, the largest insider sale at the company since 2023; 1 other insider sold within 30 days.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CSV planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Melvin C. Payne
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$2.8M
$2.4M
$1.2M
+3%
+50%
2022
$4.1M
$3.0M
$1.5M
+3%
+50%
2021
$5.3M
$20.9M
$1.9M
+158%
+54%
2020
$2.4M
$4.6M
$616.3K
+24%
+5%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$417.3M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CSV
FY Dec 2025
$417.4M
FY Dec 2024
$404.2M
FY Dec 2023
$382.5M
FY Dec 2022
$370.2M
FY Dec 2021
$375.9M
Jun 2026
$102.9M
Mar 2026
$106.1M
Dec 2025
$105.5M
Sep 2025
$102.7M
Jun 2025
$102.1M
Mar 2025
$107.1M
Dec 2024
$97.7M
Sep 2024
$100.7M
At each fiscal year end
Single quarter
Net margin, TTM
+10.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CSV
FY Dec 2025
+12.3%
FY Dec 2024
+8.2%
FY Dec 2023
+8.7%
FY Dec 2022
+11.2%
FY Dec 2021
+8.8%
Jun 2026
+11.9%
Mar 2026
+12.7%
Dec 2025
+11.6%
Sep 2025
+6.4%
Jun 2025
+11.5%
Mar 2025
+19.5%
Dec 2024
+10.1%
Sep 2024
+9.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$37.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CSV
FY Dec 2025
$40.1M
FY Dec 2024
$35.9M
FY Dec 2023
$57.6M
FY Dec 2022
$34.9M
FY Dec 2021
$59.4M
Jun 2026
$2.2M
Mar 2026
$11.0M
Dec 2025
$6.2M
Sep 2025
$18.0M
Jun 2025
$5.2M
Mar 2025
$10.6M
Dec 2024
$4.9M
Sep 2024
$16.2M
At each fiscal year end
Single quarter
Debt to equity
0.02x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CSV
FY Dec 2025
0.02x
FY Dec 2024
0.03x
FY Dec 2023
0.03x
FY Dec 2022
0.03x
FY Dec 2021
0.04x
Jun 2026
0.02x
Mar 2026
0.02x
Dec 2025
0.02x
Sep 2025
0.03x
Jun 2025
0.02x
Mar 2025
0.02x
Dec 2024
0.03x
Sep 2024
0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
9.87x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CSV
FY Dec 2025
9.81x
FY Dec 2024
9.51x
FY Dec 2023
12.60x
FY Dec 2022
15.28x
FY Dec 2021
18.72x
Jun 2026
9.87x
Mar 2026
9.94x
Dec 2025
9.81x
Sep 2025
8.37x
Jun 2025
9.62x
Mar 2025
8.48x
Dec 2024
9.51x
Sep 2024
9.51x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CSV
FY Dec 2025
+22.2%
FY Dec 2024
+17.3%
FY Dec 2023
+21.5%
FY Dec 2022
+31.2%
FY Dec 2021
+18.0%
Jun 2026
+17.3%
Mar 2026
+18.0%
Dec 2025
+22.2%
Sep 2025
+22.3%
Jun 2025
+24.8%
Mar 2025
+23.3%
Dec 2024
+17.3%
Sep 2024
+19.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CSV
FY Dec 2025
+3.9%
FY Dec 2024
+2.6%
FY Dec 2023
+2.7%
FY Dec 2022
+3.5%
FY Dec 2021
+2.8%
Jun 2026
+3.4%
Mar 2026
+3.4%
Dec 2025
+3.9%
Sep 2025
+3.7%
Jun 2025
+4.1%
Mar 2025
+3.7%
Dec 2024
+2.6%
Sep 2024
+2.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+24.5%
operating income after a 29.9% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CSV
FY Dec 2025
+30.3%
FY Dec 2024
+27.6%
FY Dec 2023
+36.5%
FY Dec 2022
+42.2%
FY Dec 2021
+36.0%
Jun 2026
+24.5%
Mar 2026
+25.8%
Dec 2025
+30.3%
Sep 2025
+28.0%
Jun 2025
+31.1%
Mar 2025
+30.8%
Dec 2024
+27.6%
Sep 2024
+31.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CSV
FY Dec 2025
+7.8%
FY Dec 2024
+6.7%
FY Dec 2023
+6.8%
FY Dec 2022
+7.0%
FY Dec 2021
+8.3%
Jun 2026
+7.2%
Mar 2026
+7.2%
Dec 2025
+7.8%
Sep 2025
+7.5%
Jun 2025
+8.1%
Mar 2025
+7.7%
Dec 2024
+6.7%
Sep 2024
+7.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.54x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CSV
FY Dec 2025
12.94x
FY Dec 2024
18.98x
FY Dec 2023
27.79x
FY Dec 2022
30.60x
FY Dec 2021
71.60x
Jun 2026
13.69x
Mar 2026
16.48x
Dec 2025
12.94x
Sep 2025
14.32x
Jun 2025
13.74x
Mar 2025
12.96x
Dec 2024
18.98x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$561.3M
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CSV
FY Dec 2025
$670.5M
FY Dec 2024
$610.9M
FY Dec 2023
$379.2M
FY Dec 2022
$408.1M
FY Dec 2021
$1.1B
Jun 2026
$612.2M
Mar 2026
$722.5M
Dec 2025
$670.5M
Sep 2025
$704.6M
Jun 2025
$721.8M
Mar 2025
$607.2M
Dec 2024
$610.9M
Sep 2024
$504.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield CSV
FY Dec 2025
+6.0%
FY Dec 2024
+5.9%
FY Dec 2023
+15.4%
FY Dec 2022
+8.6%
FY Dec 2021
+5.5%
Jun 2026
+6.1%
Mar 2026
+5.6%
Dec 2025
+6.0%
Sep 2025
+5.5%
Jun 2025
+5.2%
Mar 2025
+5.0%
Dec 2024
+5.9%
Sep 2024
+8.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -16%, PEG needs growth
PEG, trailing CSV
FY Dec 2025
0.23x
FY Dec 2024
n/a
FY Dec 2023
2.22x
FY Dec 2022
2.45x
FY Dec 2021
5.73x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
0.23x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CSV ranks highest on financial health (88th percentile) and profitability (66th), and lowest on risk and compliance (39th), among Services peers.
Profitability
66
Inputs
Return on equity+17.3% · 72 pct, sector of 207
Return on assets+3.4% · 62 pct, sector of 269
Return on invested capital+24.5% · 74 pct, sector of 81
Return on capital employed+7.2% · 55 pct, sector of 203
Financial health
88
Inputs
Debt to equity0.02x · 81 pct, sector of 228
Cash flow to debt9.87x · 95 pct, sector of 199
Growth
43
Inputs
Revenue growth, YoY+3.3% · 43 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
39
Inputs
Short interest, % of float+6.1% · 31 pct, sector of 384
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+12.8% · 47 pct, sector of 227
3 not measured: Insider conviction, Institutional and government, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.